13.20.1
IP GАZLАMА ISHLАB CHIQАRISH
152
MAS‘ULIYATI CHEKLANGAN YOKI QO‘SHIMCHA MAS‘ULIYATLI JAMIYAT
03877
O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi huzurida Farmatsevtika tarmog‘ini rivojlantirish agentligi
1703401
Республика Узбекистан, Андижанская область, Андижан
28560315
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on arbitration cases
No data on participation in public procurement as a supplier or customer
Коротко о компании
GRAND PHARM TEX has been operating since 2019 in the "Производство хлопчатобумажных тканей" industry. The director is RAXIMOV DILMURAT JAMOLDINOVICH. The company belongs to the "Small business" category. Its primary activity is "Производство хлопчатобумажных тканей". The company has 2 founders, one of whom owns a 97.1% stake. The company is not engaged in licensed activities.. The company holds property totaling 1 units, is included in 0, and has 243 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
5
0
5
0
No data on licenses
No data on trademarks
Коротко о компании
GRAND PHARM TEX has been operating since 2019 in the "Производство хлопчатобумажных тканей" industry. The director is RAXIMOV DILMURAT JAMOLDINOVICH. The company belongs to the "Small business" category. Its primary activity is "Производство хлопчатобумажных тканей". The company has 2 founders, one of whom owns a 97.1% stake. The company is not engaged in licensed activities.. The company holds property totaling 1 units, is included in 0, and has 243 similar companies, indicating a developed competitive market.